These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Thimet oligopeptidase (EC 3.4.24.15), a novel protein on the route of MHC class I antigen presentation. Silva CL; Portaro FC; Bonato VL; de Camargo AC; Ferro ES Biochem Biophys Res Commun; 1999 Feb; 255(3):591-5. PubMed ID: 10049755 [TBL] [Abstract][Full Text] [Related]
5. Thimet oligopeptidase and the stability of MHC class I epitopes in macrophage cytosol. Portaro FC; Gomes MD; Cabrera A; Fernandes BL; Silva CL; Ferro ES; Juliano L; de Camargo AC Biochem Biophys Res Commun; 1999 Feb; 255(3):596-601. PubMed ID: 10049756 [TBL] [Abstract][Full Text] [Related]
6. The cytosolic endopeptidase, thimet oligopeptidase, destroys antigenic peptides and limits the extent of MHC class I antigen presentation. York IA; Mo AX; Lemerise K; Zeng W; Shen Y; Abraham CR; Saric T; Goldberg AL; Rock KL Immunity; 2003 Mar; 18(3):429-40. PubMed ID: 12648459 [TBL] [Abstract][Full Text] [Related]
7. Characterization of a mitochondrial metallopeptidase reveals neurolysin as a homologue of thimet oligopeptidase. Serizawa A; Dando PM; Barrett AJ J Biol Chem; 1995 Feb; 270(5):2092-8. PubMed ID: 7836437 [TBL] [Abstract][Full Text] [Related]
8. Major histocompatibility complex class I-presented antigenic peptides are degraded in cytosolic extracts primarily by thimet oligopeptidase. Saric T; Beninga J; Graef CI; Akopian TN; Rock KL; Goldberg AL J Biol Chem; 2001 Sep; 276(39):36474-81. PubMed ID: 11479311 [TBL] [Abstract][Full Text] [Related]
9. Proteolysis and class I major histocompatibility complex antigen presentation. York IA; Goldberg AL; Mo XY; Rock KL Immunol Rev; 1999 Dec; 172():49-66. PubMed ID: 10631936 [TBL] [Abstract][Full Text] [Related]
10. Regulation of cell-surface major histocompatibility complex class I expression by the endopeptidase EC3.4.24.15 (thimet oligopeptidase). Kim SI; Pabon A; Swanson TA; Glucksman MJ Biochem J; 2003 Oct; 375(Pt 1):111-20. PubMed ID: 12877658 [TBL] [Abstract][Full Text] [Related]
11. Pathway for degradation of peptides generated by proteasomes: a key role for thimet oligopeptidase and other metallopeptidases. Saric T; Graef CI; Goldberg AL J Biol Chem; 2004 Nov; 279(45):46723-32. PubMed ID: 15328361 [TBL] [Abstract][Full Text] [Related]
12. Sleep deprivation changes thimet oligopeptidase (THOP1) expression and activity in rat brain. Visniauskas B; Simões PSR; Dalio FM; Naffah-Mazzacoratti MDG; Oliveira V; Tufik S; Chagas JR Heliyon; 2019 Nov; 5(11):e02896. PubMed ID: 31828230 [TBL] [Abstract][Full Text] [Related]
13. The role of neuropeptide processing enzymes in endocrine (prostate) cancer: EC 3.4.24.15 (EP24.15). Swanson TA; Kim SI; Myers M; Pabon A; Philibert KD; Wang M; Glucksman MJ Protein Pept Lett; 2004 Oct; 11(5):471-8. PubMed ID: 15544568 [TBL] [Abstract][Full Text] [Related]
14. Free ATP inhibits thimet oligopeptidase (EC 3.4.24.15) activity, induces autophosphorylation in vitro, and controls oligopeptide degradation in macrophage. Portaro FC; Hayashi MA; Silva CL; de Camargo AC Eur J Biochem; 2001 Feb; 268(4):887-94. PubMed ID: 11179954 [TBL] [Abstract][Full Text] [Related]
15. Thimet oligopeptidase--a review of a thiol dependent metallo-endopeptidase also known as Pz-peptidase endopeptidase 24.15 and endo-oligopeptidase. Tisljar U Biol Chem Hoppe Seyler; 1993 Feb; 374(2):91-100. PubMed ID: 8471182 [TBL] [Abstract][Full Text] [Related]
16. Neuropeptide specificity and inhibition of recombinant isoforms of the endopeptidase 3.4.24.16 family: comparison with the related recombinant endopeptidase 3.4.24.15. Rioli V; Kato A; Portaro FC; Cury GK; te Kaat K; Vincent B; Checler F; Camargo AC; Glucksman MJ; Roberts JL; Hirose S; Ferro ES Biochem Biophys Res Commun; 1998 Sep; 250(1):5-11. PubMed ID: 9735321 [TBL] [Abstract][Full Text] [Related]
17. Analysis of intracellular substrates and products of thimet oligopeptidase in human embryonic kidney 293 cells. Berti DA; Morano C; Russo LC; Castro LM; Cunha FM; Zhang X; Sironi J; Klitzke CF; Ferro ES; Fricker LD J Biol Chem; 2009 May; 284(21):14105-16. PubMed ID: 19282285 [TBL] [Abstract][Full Text] [Related]
18. A structure-based site-directed mutagenesis study on the neurolysin (EC 3.4.24.16) and thimet oligopeptidase (EC 3.4.24.15) catalysis. Oliveira V; Araújo MC; Rioli V; de Camargo AC; Tersariol IL; Juliano MA; Juliano L; Ferro ES FEBS Lett; 2003 Apr; 541(1-3):89-92. PubMed ID: 12706825 [TBL] [Abstract][Full Text] [Related]
19. Expression analysis of THOP1 in background liver, a prognostic predictive factor in hepatocellular carcinoma, extracted by multiarray analysis. Nomoto S; Hishida M; Inokawa Y; Takano N; Kanda M; Nishikawa Y; Fujii T; Koike M; Sugimoto H; Kodera Y Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S443-50. PubMed ID: 24604581 [TBL] [Abstract][Full Text] [Related]
20. Characterization of thimet oligopeptidase and neurolysin activities in B16F10-Nex2 tumor cells and their involvement in angiogenesis and tumor growth. Paschoalin T; Carmona AK; Rodrigues EG; Oliveira V; Monteiro HP; Juliano MA; Juliano L; Travassos LR Mol Cancer; 2007 Jul; 6():44. PubMed ID: 17620116 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]